Altamira Therapeutics Ltd. (CYTOF) Capital expenditures
Altamira Therapeutics Ltd. (CYTOF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$103,087FY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $103,087 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More CYTOF financial trends
CYTOF RevenueCYTOF Net incomeCYTOF Net marginCYTOF Gross profitCYTOF Gross marginCYTOF Operating incomeCYTOF Operating marginCYTOF Operating cash flowCYTOF Free cash flowCYTOF Return on equityCYTOF Stock buybacksCYTOF Dividends paidCYTOF Total assetsCYTOF Total liabilitiesCYTOF Shareholders’ equityCYTOF overview →